We are live on ! Find out more
PMN icon

ProMIS Neurosciences

15 hedge funds and large institutions have $3.85M invested in ProMIS Neurosciences in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

7% more funds holding

Funds holding: 1415 (+1)

0.1% more ownership

Funds ownership: 0.61%0.71% (+0.1%)

31% less capital invested

Capital invested by funds: $5.61M → $3.85M (-$1.76M)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
IC
IEQ Capital
California
-$12.6K

PMN Hedge Fund Activity: Q4 2023 in Review

15 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q4 2023, worth a combined $3.85M — down 31% from $5.61M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PMN positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Ally Bridge Group, adding an estimated $800K. The largest seller was IEQ Capital, cutting an estimated $12.6K.

  • 15 institutional investors held ProMIS Neurosciences (PMN) as of Q4 2023, up from 14 in Q3 2023.
  • Funds reported $3.85M of ProMIS Neurosciences stock for Q4 2023, down 31% quarter-over-quarter.
  • 1 fund opened new ProMIS Neurosciences positions in Q4 2023 and 0 closed out, a net change of +1 holder.
  • The largest ProMIS Neurosciences buyer in Q4 2023 was Ally Bridge Group, an estimated $800K added.
  • The largest ProMIS Neurosciences seller in Q4 2023 was IEQ Capital, an estimated $12.6K sold.

Based on aggregated 13F filings for Q4 2023.